Răzvan Popescu

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

James M. Foran, A. Z. S. Rohatiner, David Cunningham et al. · Journal of Clinical Oncology · 2000 · 471 citations

Adjuvant or Palliative Chemotherapy for Colorectal Cancer in Patients 70 Years or Older

Răzvan Popescu, A. Norman, Paul J. Ross et al. · Journal of Clinical Oncology · 1999 · 265 citations

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 139 citations · Full text

Sakk 41/06, Gastrointestinal Oncology, Medicine +9

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

Paul J. Ross, A. Norman, David Cunningham et al. · Annals of Oncology · 1997 · 128 citations · Full text

Surgical Oncology, Mitomycin C, Medicine +8